Bharat Parenterals (BOM:541096) Cyclically Adjusted Revenue per Share: ₹477.35 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:541096 Bharat Parenterals Ltd BOM:541096
68 GF Score
Price ₹1,522.45
GF Value ₹1,210.22
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bharat Parenterals Cyclically Adjusted Revenue per Share?

Bharat Parenterals BOM:541096 -0.75% 68 Cyclically Adjusted Revenue per Share is ₹477.35 as of Jun. 2026. GuruFocus rates BOM:541096 with a GF Score™ of 68/100 and a GF Value™ of ₹1,210.22 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bharat Parenterals's adjusted revenue per share for the three months ended in Jun. 2026 was ₹136.008. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹477.35 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bharat Parenterals's average Cyclically Adjusted Revenue Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-02), Bharat Parenterals's current stock price is ₹1522.45. Bharat Parenterals's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹477.35. Bharat Parenterals's Cyclically Adjusted PS Ratio of today is 3.19.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bharat Parenterals was 4.33. The lowest was 2.05. And the median was 2.83.


Bharat Parenterals  (BOM:541096) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bharat Parenterals's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1522.45/477.35
=3.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bharat Parenterals was 4.33. The lowest was 2.05. And the median was 2.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bharat Parenterals Cyclically Adjusted Revenue per Share Related Terms


Bharat Parenterals Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bharat Parenterals's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Parenterals Cyclically Adjusted Revenue per Share Chart

Bharat Parenterals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 422.66 461.64

Bharat Parenterals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 438.76 449.91 455.30 461.64 477.35

BOM:541096 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bharat Parenterals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Parenterals Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bharat Parenterals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bharat Parenterals's Cyclically Adjusted PS Ratio falls into.


BOM:541096
68GF Score
Bharat Parenterals Ltd BOM:541096
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Parenterals Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bharat Parenterals's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=136.008/167.3573*167.3573
=136.008

Current CPI (Jun. 2026) = 167.3573.

Bharat Parenterals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 46.669 105.961 73.710
201612 47.188 105.196 75.072
201703 57.851 105.196 92.036
201706 47.319 107.109 73.936
201709 64.631 109.021 99.214
201712 56.276 109.404 86.087
201803 70.086 109.786 106.838
201806 64.921 111.317 97.605
201809 88.304 115.142 128.349
201812 156.193 115.142 227.025
201903 73.134 118.202 103.547
201906 86.579 120.880 119.868
201909 86.815 123.175 117.955
201912 129.428 126.235 171.590
202003 95.560 124.705 128.244
202006 95.745 127.000 126.170
202009 103.998 130.118 133.762
202012 86.475 130.889 110.569
202103 70.402 131.771 89.415
202106 106.178 134.084 132.526
202109 105.447 135.847 129.906
202112 66.586 138.161 80.657
202203 90.596 138.822 109.218
202206 45.264 142.347 53.217
202209 141.916 144.661 164.182
202212 102.305 145.763 117.461
202303 87.507 146.865 99.717
202306 121.140 150.280 134.906
202309 101.943 151.492 112.619
202312 94.952 152.924 103.914
202403 109.109 153.035 119.321
202406 141.800 155.789 152.330
202409 109.795 157.882 116.384
202412 132.934 158.323 140.520
202503 150.868 157.552 160.258
202506 168.310 159.755 176.319
202509 124.966 162.289 128.869
202512 94.585 163.281 96.946
202603 144.550 164.272 147.265
202606 136.008 167.357 136.008

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹477.35 mean?
Bharat Parenterals (BOM:541096) has a Cyclically Adjusted Revenue per Share of ₹477.35 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bharat Parenterals and its competitors.
Is Bharat Parenterals' Cyclically Adjusted Revenue per Share too high?
Bharat Parenterals' current Cyclically Adjusted Revenue per Share is ₹477.35. Overall, Bharat Parenterals has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bharat Parenterals' Cyclically Adjusted Revenue per Share compare to ZTS?
Bharat Parenterals' Cyclically Adjusted Revenue per Share of ₹477.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bharat Parenterals and its competitors. Bharat Parenterals's current Cyclically Adjusted Revenue per Share is ₹477.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Parenterals stock overvalued right now?
Based on GuruFocus' analysis, Bharat Parenterals (BOM:541096) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,210.22, compared to a current price of ₹1,522.45 — trading 25.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹477.35. Bharat Parenterals' overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bharat Parenterals (BOM:541096), the current Cyclically Adjusted Revenue per Share is ₹477.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bharat Parenterals (BOM:541096) Overvalued in 2026?

Based on GuruFocus' analysis, Bharat Parenterals stock appears to be overvalued. The current stock price of ₹1,522.45 is trading 25.8% above its estimated GF Value™ of ₹1,210.22. GuruFocus considers Bharat Parenterals to be Modestly Overvalued.

Key valuation signals for BOM:541096:

  • Cyclically Adjusted Revenue per Share: ₹477.35
  • GF Value™: ₹1,210.22 vs. price of ₹1,522.45 (25.8% above fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the BOM:541096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bharat Parenterals Business Description

Other Exchanges BPLPHARMA:India
Address Survey No.144-A, Jarod Samlaya Road, Village Haripura, Tehsil Savli, Vadodara, GJ, IND, 391520
Bharat Parenterals Ltd is a pharmaceutical company. It provides various products such as Capsules, Dry Syrups, Sachets, Oral Liquids, Injections, Semisolids, and others. Geographically, the group has a business presence in India and Outside India.
68GF Score

Get the complete analysis for BOM:541096

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,522.45
Price
₹1,210.22
GF Value